Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial AM Borobia, AJ Carcas, M Pérez-Olmeda, L Castaño, MJ Bertran, ... The Lancet 398 (10295), 121-130, 2021 | 425 | 2021 |
A cohort of patients with COVID-19 in a major teaching hospital in Europe AM Borobia, AJ Carcas, F Arnalich, R Álvarez-Sala, J Monserrat-Villatoro, ... Journal of clinical medicine 9 (6), 1733, 2020 | 329 | 2020 |
Heart failure in COVID‐19 patients: prevalence, incidence and prognostic implications JR Rey, J Caro‐Codón, SO Rosillo, ÁM Iniesta, S Castrejón‐Castrejón, ... European journal of heart failure 22 (12), 2205-2215, 2020 | 245 | 2020 |
Acute respiratory distress syndrome after convalescent plasma use: treatment of a patient with Ebola virus disease contracted in Madrid, Spain M Mora-Rillo, M Arsuaga, G Ramírez-Olivencia, F de la Calle, AM Borobia, ... The Lancet Respiratory Medicine 3 (7), 554-562, 2015 | 146 | 2015 |
Overuse of PPIs in patients at admission, during hospitalisation, and at discharge in a terciary Spanish hospital E Ramirez, S H Lei, A M Borobia, E Pinana, S Fudio, R Muñoz, A Campos, ... Current clinical pharmacology 5 (4), 288-297, 2010 | 117 | 2010 |
Characterization of NT‐proBNP in a large cohort of COVID‐19 patients J Caro‐Codón, JR Rey, A Buño, AM Iniesta, SO Rosillo, ... European journal of heart failure 23 (3), 456-464, 2021 | 104 | 2021 |
Clinical trial to test the efficacy of melatonin in COVID‐19 D Acuña‐Castroviejo, G Escames, JC Figueira, P de la Oliva, AM Borobia, ... Journal of pineal research 69 (3), e12683, 2020 | 100 | 2020 |
Acceptability and characteristics of 124 human bioequivalence studies with active substances classified according to the Biopharmaceutic Classification System E Ramirez, O Laosa, P Guerra, B Duque, B Mosquera, AM Borobia, ... British journal of clinical pharmacology 70 (5), 694-702, 2010 | 97 | 2010 |
Trough tacrolimus concentrations in the first week after kidney transplantation are related to acute rejection AM Borobia, I Romero, C Jimenez, F Gil, E Ramirez, R De Gracia, ... Therapeutic drug monitoring 31 (4), 436-442, 2009 | 95 | 2009 |
Development and validation of a prediction model for 30-day mortality in hospitalised patients with COVID-19: the COVID-19 SEIMC score J Berenguer, AM Borobia, P Ryan, J Rodríguez-Baño, JM Bellón, I Jarrín, ... Thorax 76 (9), 920-929, 2021 | 91 | 2021 |
A pharmacovigilance program from laboratory signals for the detection and reporting of serious adverse drug reactions in hospitalized patients E Ramirez, AJ Carcas, AM Borobia, SH Lei, E Piñana, S Fudio, J Frias Clinical Pharmacology & Therapeutics 87 (1), 74-86, 2010 | 85 | 2010 |
An acenocoumarol dosing algorithm using clinical and pharmacogenetic data in Spanish patients with thromboembolic disease AM Borobia, R Lubomirov, E Ramírez, A Lorenzo, A Campos, ... PloS one 7 (7), e41360, 2012 | 81 | 2012 |
Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study B Gutiérrez-Gutiérrez, MD Del Toro, AM Borobia, A Carcas, I Jarrín, ... The Lancet infectious diseases 21 (6), 783-792, 2021 | 79 | 2021 |
Effect of the most relevant CYP3A4 and CYP3A5 polymorphisms on the pharmacokinetic parameters of 10 CYP3A substrates M Saiz-Rodríguez, S Almenara, M Navares-Gómez, D Ochoa, M Román, ... Biomedicines 8 (4), 94, 2020 | 76 | 2020 |
Significant HLA class I type associations with aromatic antiepileptic drug (AED)-induced SJS/TEN are different from those found for the same AED-induced DRESS in the Spanish … E Ramírez, T Bellón, HY Tong, AM Borobia, FJ de Abajo, V Lerma, ... Pharmacological research 115, 168-178, 2017 | 73 | 2017 |
Symptomatic thromboembolic events in patients treated with intravenous-immunoglobulins: results from a retrospective cohort study E Ramírez, JA Romero-Garrido, E López-Granados, AM Borobia, T Pérez, ... Thrombosis research 133 (6), 1045-1051, 2014 | 68 | 2014 |
Appropriate use of red blood cell transfusion in emergency departments: a study in five emergency departments MQ Díaz, AM Borobia, JAG Erce, C Maroun-Eid, S Fabra, A Carcas, ... Blood Transfusion 15 (3), 199, 2017 | 67 | 2017 |
Evaluation of the influence of sex and CYP2C19 and CYP2D6 polymorphisms in the disposition of citalopram S Fudio, AM Borobia, E Piñana, E Ramírez, B Tabarés, P Guerra, ... European journal of pharmacology 626 (2-3), 200-204, 2010 | 64 | 2010 |
Inhaled methoxyflurane provides greater analgesia and faster onset of action versus standard analgesia in patients with trauma pain: InMEDIATE: a randomized controlled trial in … AM Borobia, SG Collado, CC Cardona, RC Pueyo, CF Alonso, IP Torres, ... Annals of emergency medicine 75 (3), 315-328, 2020 | 59 | 2020 |
GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19 E Pairo-Castineira, K Rawlik, AD Bretherick, T Qi, Y Wu, I Nassiri, ... Nature 617 (7962), 764-768, 2023 | 58 | 2023 |